In this exclusive video, Anita Afzali, MD, director of the inflammatory bowel disease center at The Ohio State University, discusses the impact of emerging therapies in IBD.

In addition to filling in some of the unmet needs in IBD care, Afzali said new therapies could help physicians provide a more personalized approach for their patients.

Full Article: